Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined with Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer
Study Type: Treatment
Phase: I/II
NCTID: NCT06287775
Principal Investigator:
Chao Huang
A Randomized Phase III Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamicin with or without Venetoclax in Children with Relapsed AML
Study Type: Treatment
Phase: III
NCTID: NCT05183035
Principal Investigator:
Kevin Ginn
Docetaxel addition in Metastatic Castrate-Sensitive Prostate Cancer ASPIRE
Study Type: Treatment
Phase: III
NCTID: NCT06931340
Principal Investigator:
Elizabeth Wulff
A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission CR1 Following Induction Therapy PTCL-STAT
Study Type: Treatment
Phase: III
NCTID: NCT06724237
Principal Investigator:
Marc Hoffmann
A Phase Ib Study of Menin Inhibitor SNDX-5613 in Combination with Daunorubicin and Cytarabine in Newly Diagnosed Patients with Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged Disease or NUP98 Alterations
Study Type: Treatment
Phase: I
NCTID: NCT05886049
Principal Investigator:
Jesus Gonzalez Lugo
Randomized Phase III Trial of Mfolfirnox +/- Nivolumab Vs. Folfox +/- Nivolumab for First-line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma
Study Type: Treatment
Phase: III
NCTID: NCT05677490
Principal Investigator:
Gary Doolittle
A Phase III, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Study Type: Treatment
Phase: III
NCTID: NCT07043400
Principal Investigator:
Raed Al-Rajabi
Multi-arm Phase II Study OF Ubamatamab REGN4018; MUC16�CD3 Bispecific Antibody With or Without Additional Agents in Platinum-resistant Ovarian Cancer
Study Type: Treatment
Phase: II
NCTID: NCT06787612
Principal Investigator:
Melissa Javellana
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
Study Type: Diagnostic
Phase: N/A
NCTID: NCT03865589
Principal Investigator:
Sherwin Chan
Complementary Options for Symptom Management In Cancer COSMIC: Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06418204
Principal Investigator:
Nina Mathew